Travere Therapeutics, Inc.
2020 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 1,517 | 0.0% | 39,696 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 653 | 0.0% | 44,102 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 743 | 0.0% | 41,489 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 476 | 0.0% | 27,338 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 658 | 0.0% | 47,045 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 239 | 0.0% | 29,114 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 222 | 0.0% | 28,850 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 334 | 0.0% | 37,202 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 335 | 0.0% | 37,443 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 453 | 0.0% | 29,519 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 554 | 0.0% | 24,629 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 514 | 0.0% | 24,460 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 13,399 | 0.0% | 543,789 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 13,188 | 0.0% | 544,293 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 14,020 | 0.0% | 544,046 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 16,871 | 0.0% | 549,488 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 17,119 | 0.0% | 705,925 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 10,351 | 0.0% | 709,502 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 57,678 | 0.1% | 2,309,887 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 59,603 | 0.1% | 2,186,830 | 12/31/2020 |